
Between 2023 and 2026 several clinical practice guidelines changed what is recommended in general practice: fewer opioids, fewer antibiotics, less tissue removed, and radiographs based on risk. This digest gathers twelve points, each with its figure and its source, for colleagues who want to catch up in ten minutes.
It is not a guideline and does not replace reading the original documents. It covers what was published up to November 11, 2026.
The 2024 ADA guideline for adolescents and adults recommends ibuprofen 400 mg or naproxen sodium 440 mg as first-line therapy, alone or with acetaminophen 500 mg. Opioids are for limited cases and rarely for more than three days. All recommendations are conditional, with low certainty.
The OARS trial (JADA 2025; 1,815 adults after impacted third-molar extraction) found better pain control with ibuprofen plus acetaminophen than with hydrocodone plus acetaminophen.
The ADA Council on Scientific Affairs statement (JADA, October 2026) notes that dental antibiotic prescribing did not change between 2012 and 2022 and accounts for about 10% of outpatient prescriptions. It keeps the 2019 guideline as its basis, which does not indicate antibiotics for irreversible pulpitis.
The 2026 Cochrane update concludes, with moderate certainty, that a single preoperative dose of amoxicillin probably reduces early implant failure (relative risk 0.34; about 19 patients treated to prevent one failure). Not all analyses agree on the size of the benefit in healthy patients.
The ADA and AAOMR recommendations (JADA, January 2026) replace the 2012 document as the reference: bitewings every 24 to 36 months for low-risk adults and every 6 to 18 months with caries or high risk, always after the clinical exam. It is a consensus, not a formal guideline.
Since February 2024 the ADA no longer recommends lead aprons or thyroid collars for any patient. Before changing a protocol, check the current state rule.
During 2026 the ADA is publishing its first living guideline on potentially malignant disorders, replacing the 2017 guideline: a clinical exam for every adult and biopsy as the standard. Cytology, vital staining and light-based devices receive a conditional recommendation against.
The 2023 ADA restorative guideline supports selective or stepwise removal in deep lesions of vital teeth. The 2021 AAE statement on vital pulp therapy calls for complete removal: an open disagreement between societies.
The EFP S3 guideline organizes treatment in four steps and does not recommend lasers, photodynamic therapy or probiotics as adjuncts to subgingival instrumentation. Systemic antibiotics are for specific cases.
The 2023 BMJ guideline strongly recommends cognitive behavioral therapy, supervised jaw exercises and mobilization. It is conditionally against reversible splints and botulinum toxin, and strongly against irreversible occlusal procedures.
The 2023 Cochrane review (47 trials, 4,377 participants) finds low or very low certainty for preferring one type of retainer over another.
The AHA scientific statement, published online in December 2025, maintains that a causal link between periodontitis and cardiovascular disease is not confirmed and that there is no direct evidence that periodontal treatment prevents events.
Treating periodontitis lowers HbA1c by 0.43 points at 3 to 4 months (Cochrane 2022, moderate certainty). Daily toothbrushing in hospitalized patients reduces hospital-acquired pneumonia (relative risk 0.67; JAMA Internal Medicine 2024), with the benefit shown in mechanically ventilated patients.
Each point links to its original source. Abbreviations: ADA, American Dental Association; AAOMR, American Academy of Oral and Maxillofacial Radiology; AAE, American Association of Endodontists; EFP, European Federation of Periodontology; AHA, American Heart Association; PBRN, Practice-Based Research Network. If you spot an error or a newer guideline, write to us and we will correct it.
For patients, the same topics are explained in plain language in how long do fillings last and fluoride, hydroxyapatite or 5,000 ppm toothpaste.
Informational digest for professionals. It is not a clinical guideline and does not replace professional judgment or the original documents. PureSmile Miami, 8000 SW 117th Ave, Suite 100, Miami, FL 33183. Yoan Suárez Zayas, DMD · FL Lic. DN 21413.